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SUMMARY.-The well-known peak of bone cancer during the second decade
was found to be closely associated with changes in growth velocity at the
adolescent growth spurt, for males and females in England and Wales. Distinct
accumulations in the second and third decades could be recognized for cancers
ofovary, testis, prostate andthyroid. Itwassuggestedthattheseaccumulations
and also the bone cancer peak might be a consequence of the growth and
development which occur at puberty.
THE relationship between cancer mortality and age has been much studied to
shed light on carcinogenesis. The following analysis indicates that for some
cancers distinct changes in rates during the second and third decades might be
associated with the growth and development which occur at puberty.
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FIG. 1.-Comparison of growth velocity curves (Tanner et al., 1966) with histograms for bone
cancer mortality in England and Wales, 1958-63; males , females -----BONE CANCER AETIOLOGY IN THE YOUNG
TABLE I.-Modal Aye*
Data
Tissue Country Sex Mortality Registration
Bone . . E. &W. . M 18 18
F 16i 15
Ovary . . E. & W. . F (18) (19)
U.S. F (19)
Prostate . E. & W. . M 18
U.S. M . 19i -
Testis . . E. & W. . M 29 33
Thyroid. . E. & W. M . - (28)
E. & W. . F (33)
Breast . . See de Waard
(1969) 40_50 -
* Parentheses indicate an estimate based on an assumed linear extrapolation.
Bone Cancer
It is well known that osteosarcoma, a tumour which occurs mainly in the
young, isgenerallylocated at sites ofmaximumgrowth. Fig. 1 showsacomparison
ofgrowth velocities (Tanner, Whitehouse and Takaishi, 1966) with mortality rates
for bone cancer (I.C.D. 196)t; the mortality rates were means of annual values
for England and Wales during the period 1958-63 (Registrar General, 1958-63).
The similarity betweenthe age distribution ofthe adolescentgrowth spurtandbone
cancer mortality was striking.
For the adolescent growth spurt the maximum growth velocity occurred at
12 years for girls and 14 years for boys (Tanner, Whitehouse and Takaishi, 1966).
The estimated modal ages for bone cancer mortality were approximately 4 years
later at 18 years for males and 161 years for females (Table I). The age distribu-
tion of bone cancer registrations, available for the period 1962-64 (Registrar
General, 1968), was similar to that shown in Fig. 1 for mortality rates. For
registrations the estimated modal ages were 18 years for males and 15 years for
females (Table I). With an allowance for the time required for symptoms to
develop it was clear that changes in bone tumour development followed closely the
growth changes at adolescence, with a lag of less than 2 or 3 years.
Other Cancers
Because the gonads and other organs also develop rapidly at puberty it was
ofinterest to examine mortality rates for cancer ofthose organs.
Ovary
Average age-specific mortality rates for ovarian cancer (I.C.D. 175) were
calculated for England and Wales for the 12-year period 1955-66 (Registrar
General, 1955-66). Changes in mortality rate during the second and third
decades were not obviously different from changes in later decades.
However, when log (Rate) was plotted against age, rate changes below 30
years could be seen to differ from those above 30 years (Fig. 2). Similar results
were obtained for the United States; the rates were mean values for the period
t I.C.D. Seventh Revision.
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FiGc. 2.-Ovarian cancer mortality in England ancl Wales (1955-66) and the U.S. (1962-65).
1962-65 calculated from data compiled by Segi and Kurihara (1966, 1969). Log
(Rate) for ages above 30 years lay close to a straight line. This line was extra-
polated to younger ages and deviations ofthe observed rate from it assumed to be a
measure of those ovarian cancers which were distinct for ages less than 30 years.
Modal ages for these deviations were 18 years for England and Wales and 19 years
for the United States (Table I). The number of cancers represented by these
deviations was approximately one half ofthe total mortality from ovarian cancers
occurring at ages less than 30 years. The precision of this estimate depends of
course upon the validity of the assumption of linear extrapolation.
When the analysis was repeated for rates of registration of ovarian cancer
(Registrar General, 1968) in England and Wales the modal age was 19 years
(Table I).
Testis
Mean, age-specific mortality rates for cancer of the testis (I.C.D. 178) were
calculated for England and Wales for the period 1955-66 (Registrar General,
1955-66). Rates rose to a maximum at 29 years (Table I). No distinct changes
in the rate of increase could be detected for younger ages. Mean registration
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rates for the period 1962-64 (Registrar General, 1968) had a modal age of 33 years
(Table I).
Prostate
For the United States and England and Wales the age-specific rate for cancer
of the prostate (I.C.D. 177) rose to a peak at the end ofthe second decade (Table
I). The number of cases was, of course, extremely small and the peak during the
second decade was of interest only because of its possible association with growth
of the prostate at puberty.
Thyroid
For ages above 40 years the mean registration rate for thyroid cancer (I.C.D.
194) in England and Wales for the period 1962-64 increased linearly with age
(Fig. 3). Below 40 years the rates showed a pronounced peak in the third
decade (Fig. 3). When the straight part ofthe curve was extrapolated to younger
ages and subtracted from the recorded rate the differences had a modal age of 28
years for males and 33 for females (Table I).
Breast
Breast cancer is extremely rare at ages below 20 years (Close and Maximov,
1965). There is some evidence reviewed recently by de Waard (1969) for a distinct
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FiG. 3.-Thyroid cancer registration in England and Wales, 1962-64.
211group ofbreast cancers with a modal age ofabout 40-50 years. Scrutiny ofbreast
cancer rates did not indicate any earlier accumulation.
DISCUSSION
The above analysis has indicated that for several tissues the age dependence
of cancer rates differed during the second and third decades from the dependence
at later ages.
For bone cancer the early rates were strikingly associated with changes in
growth velocity at the adolescent growth spurt. Rates rose to a higher value for
males, and at an interval of 2 or 3 years later, than for females, resembling closely
the characteristics of the adolescent growth spurt. The histogram for females
would be consistent with a steeply rising peak with a modal age of 15-16 years
(Fig. 1). The association between bone cancer andgrowth would be more intimate
if the adolescent growth spurt were the culmination of processes which increased
from birth onwards. This is not unreasonable since the rapid fall of growth
velocity after birth could be a decline in the foetal state of activity of tissues, a
state which does not appear to extend beyond the second or third year of life
(Hubble, 1969).
Skeletal growth is a chondroplasia accompanied by osteogenesis. Chondro-
sarcoma does not appear untillate inlife (Sissons, 1958) whileosteosarcoma appears
earlier and would constitute the majority of bone tumours which were associated
with the adolescent growth spurt. It might be therefore that bone cancer develop-
ment was associated with processes of skeletal maturation (osteogenesis) rather
than skeletal enlargement (chondroplasia). Factors associated with skeletal
maturation have been summarized recently by Hubble (1969) and include thyrox-
ine, androgens and oestrogen. It wouldbe ofinterest to establish whether children
with osteosarcoma had an advanced or a delayed skeletal maturation and whether
any characteristic disturbance of hormone levels could be recognized.
Lee (1961) described a peak in leukaemia rates during the second decade oflife
and drew attention to the increased rate of bone cancer in males during the same
period, mentioning that growth at adolescence might be one of the contributing
factors. The present study has shown that the association between bone cancer
and growth is too close to be casual. Two features of the leukaemia peak,
described by Lee, suggest that this also might be associated with adolescent
growth. Firstly, the peak was higher for males than for females and occurred a
few years later. Secondly, the increase appeared to be confined to myeloid
leukaemia. Furthermore, the leukaemias had an exceptionally brief history
suggesting that they had an aetiology distinct from other leukaemias in childhood.
Increased cancer development following growth at adolescence appeared to
occur for several other tissues. For ovary and prostate the rate change occurred
during the second decade. The accumulation of cancers of the testis and thyroid
did not appear until the end ofthe third decade and ifthese were to be attributed
to adolescent growth the intervening period would need to be about 15 years. It
would be of interest to determine whether characteristic patterns of hormone
levels could be recognized for patients who developed early tumours of ovary,
testis or prostate. This is likely to be more difficult for these tissues because the
tumours might secrete hormones themselves. Also, for the ovary and prostate
the proposed " early " group accounted for only a very small proportion of the
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total. The role of pubertal changes could be more effectively studied if the early
tumours were of a distinct histological type. For instance dysgerminoma is
more frequent during the second decade (Mueller, 1950). Also ovarian sarcoma
and solid ovarian carcinoma are relatively more common in the young than older
age groups (Huffman, 1968).
The greater incidence of thyroid cancer in women suggests that sex hormones
are involved. Rawson and Leeper (1968) have suggested that the presence ofsex
hormones is associated with benign conditions ofthyroid growth. Thus the early
group of deaths from thyroid cancer might appear in patients with inadequate
levels of sex hormones.
The development of breast cancer is profoundly influenced by child bearing,
particularlyifthisoccursearly (seeColeandMacMahon, 1969). ColeandMacMahon
(1969) have proposed that the lower risk might be a consequence of the changed
hormonal levels during pregnancy. Lilienfeld (1963) suggests that marital
status-that is, presumably, child-bearing-influences development of breast
cancer late in life. Thus if abnormalities in the development at puberty of
production of sex hormones also contributed to development of breast cancer the
effect might not appear until late in life. Whether pubertal growth contributes
to the group of breast cancers in middle age is a matter, at the moment, for
speculation.
The incidence of thyroid cancer following X-irradiation of the thyroid was an
order of magnitude higher when the exposure occurred before puberty compared
with exposure in adulthood. Hempelmann (1968) has pointed out that, in
keeping with a multi-stage theory for carcinogenesis, events initiated by X-rays
could be promoted by the normal growth ofthe thyroid at puberty. This promo-
tion would be absent if exposure took place in adulthood. It is of interest to
speculate that exposure of bone, ovary, testis and prostate to carcinogens might
give higher yield of cancers if the exposure occurred before puberty. Armitage
and Doll (1957) have accounted satisfactorily for age-specific cancer rates through-
out adult life by assuming a two-stage mechanism with an intervening exponential
growth. This theory might also fit the age distribution of the early cancers
discussed in this paper if the exponential term were replaced by a function which
described natural growth at puberty.
The author wishes to express his grateful thanks to Miss Alice Duncan for her
painstaking technical assistance.
REFERENCES
ARMITAGE, P. AND DOLL, R.-(1957) Br. J. Cancer, 11, 161.
CLOSE, M. B. AND MAXIMOV, N. G.-(1965) Archs Surg., Chicago, 91, 386.
COLE, P. AND MACMAHON, B.-(1969) Lancet, i, 604.
HEMPELMANN, L. H.-(1968) 'Thyroid Neoplasia', edited by S. Young and D. C. Inman.
New York (Academic Press), p. 267.
HUBBLE, D.-(1969) 'Paediatric Endocrinology'. Oxford (Blackwell).
HUFFMAN, J. W.-(1968) 'The Gynaecology of Childhood and Adolescence'. Phila-
delphia (W. B. Saunders, Co.).
LEE, J. A. H.-(1961) Br. med. J., i, 989.
LILIENFELD, A. M.-(1963) Cancer Res., 23, 1503.
MUELLER, C.-(1950) Am. J. Obstet. Gynec., 60, 153.214 G. HEMS
RAWSON, R. W. AND LEEPER, R.-(1968) 'Thyroid Neoplasia', edited by S. Young
and D. C. Inman. New York (Academic Press), p. 159.
REGISTRAR GENERAL'S Statistical Review of England and Wales (1955-66). London
(H.M. Stationery Office).
REGISTRAR GENERAL'S Statistical Review of England and Wales (1968) Supplement
Cancer for 1962-64. London (H.M. Stationery Office).
SEGI, M. AND KURIHARA, M.-(1966)' CancerMortalityforSelected Sitesin24Countries',
No. 4. Department of Public Health, Tohoku University, Sendai, Japan.
(1969) ' Cancer Mortality for Selected Sites in 24 Countries ', No. 5. Department
of Public Health, Tohoku University, Sendai, Japan.
SISSONS, H. A.-(1958) 'Cancer', edited by R. W. Raven. London (Butterworth
& Co.), Vol. 2, p. 324.
TANNER, J. M., WHITEHOUSE, R. H. AND TAKAISHI, M.-(1966) Archs Dis. Childh.,
41, 454, 613.
DE WAARD. F. (1969) Int. J. Cancer, 4, 577.